Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zecotek Imaging China is the Shanghai-based subsidiary of Zecotek Photonics Inc., focused on the development and commercialization of advanced scintillation crystals and photo-detectors for the medical imaging market. The company's core technology is the patented Lutetium Fine Silicate (LFS) crystal, which provides high light yield and ultra-fast decay times essential for high-resolution Positron Emission Tomography (PET) scanners. Additionally, the company produced Micro-pixel Avalanche Photodiodes (MAPD), a solid-state alternative to traditional photomultiplier tubes, designed for use in integrated PET/MRI systems. While the company established manufacturing partnerships in China to scale its LFS crystal production, its parent company has faced significant financial and regulatory challenges, leading to a cessation of active operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zecotek Imaging China.